Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pPB-PGK-destination Citations (2)

Originally described in: Resetting Transcription Factor Control Circuitry toward Ground-State Pluripotency in Human.
Takashima Y, Guo G, Loos R, Nichols J, Ficz G, Krueger F, Oxley D, Santos F, Clarke J, Mansfield W, Reik W, Bertone P, Smith A Cell. 2014 Sep 11;158(6):1254-69. doi: 10.1016/j.cell.2014.08.029.
PubMed Journal

Articles Citing pPB-PGK-destination

Articles
Bioengineering hemophilia A-specific microvascular grafts for delivery of full-length factor VIII into the bloodstream. Neumeyer J, Lin RZ, Wang K, Hong X, Hua T, Croteau SE, Neufeld EJ, Melero-Martin JM. Blood Adv. 2019 Dec 23;3(24):4166-4176. doi: 10.1182/bloodadvances.2019000848. PubMed
Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer. Palakurthi B, Fross SR, Guldner IH, Aleksandrovic E, Liu X, Martino AK, Wang Q, Neff RA, Golomb SM, Lewis C, Peng Y, Howe EN, Zhang S. Nat Commun. 2023 Apr 13;14(1):2109. doi: 10.1038/s41467-023-37727-y. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.